Evidence method
Level · gp.fundamentals.capex_revenue_ratio
7.18% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
RXST · Jun 30, 2026
RxSight, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001193125-26-335153General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-35.01% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
-19.01% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
136.25% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.operating_margin
-50.55% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
33.91% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
27.40% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History11 statesHistory building
Dec 31, 20230/8 normalizedLevel 3Mar 31, 20240/7 normalizedLevel 3Jun 30, 20240/7 normalizedLevel 3Sep 30, 20240/7 normalizedLevel 3Dec 31, 20240/8 normalizedLevel 3Mar 31, 20250/8 normalizedLevel 3Jun 30, 20250/8 normalizedLevel 3Sep 30, 20250/8 normalizedLevel 3Dec 31, 20257/8 normalizedLevel 3Mar 31, 20267/8 normalizedLevel 3Jun 30, 20266/7 normalizedLevel 3
Period transition
What moved in the state?
- Previous
- 2.46%
- Current
- 7.18%
- Delta
- 4.72%
- Previous
- -35.25%
- Current
- -35.01%
- Delta
- 0.24%
- Previous
- -18.48%
- Current
- -19.01%
- Delta
- -0.54%
- Previous
- 112.87%
- Current
- 136.25%
- Delta
- 23.38%
- Previous
- -57.71%
- Current
- -50.55%
- Delta
- 7.16%
- Previous
- 30.66%
- Current
- 33.91%
- Delta
- 3.25%
- Previous
- 25.72%
- Current
- 27.40%
- Delta
- 1.69%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Compared To · Ophthalmic Goods peers →Has State · RxSight, Inc. →Transitioned To · RXST Fundamental State →Transitioned To · RXST CAPEX_INTENSITY_INCREASED →Transitioned To · RXST CASH_GENERATION_INCREASED →Transitioned To · RXST GROWTH_DECREASED →Transitioned To · RXST INVENTORY_PRESSURE_INCREASED →Transitioned To · RXST PROFITABILITY_INCREASED →Transitioned To · RXST R_AND_D_INTENSITY_INCREASED →Transitioned To · RXST SBC_INTENSITY_INCREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.